Web-based Screening and Tailored Support for Breast Cancer Patients at the Onset of the Survivorship Phase
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Change from 6 to 12 weeks follow-up in optimism and control over the future
Patients' optimism and control over the future will be measured by the subscale 'increased optimism and control over the future' of the 'Constructs Empowering Outcomes Questionnaire'. The subscale 'optimism and control over the future' represents a single concept/outcome measure. The concept cannot be assessed at baseline due to the retrospective nature of the questionnaire.
6 and 12 weeks
A.K.L. Reyners, MD, PhD
University Medical Centre Groningen
Netherlands: Medical Ethics Review Committee (METC)